Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04388605 · ClinicalTrials.gov registry record

Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic

A clinical trial of Pregnancy Related and Corona Virus Infection, sponsored by University of California, San Francisco.

Active
Registry status
7,965
Enrollment target
1
Study location

NCT04388605 is a study of Pregnancy Related and Corona Virus Infection that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 7,965 participants, above the 1,883-participant average among 99 other Pregnancy Related trials with a reported enrollment target (323% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04388605, a study of Pregnancy Related and Corona Virus Infection, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
7,965 participants
Enrollment target
1
Study location

Study Summary

Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 7,965 participants
Start Date 2020-04-21
Est. Completion 2026-12

What the Registry Record Tells You About NCT04388605

The ClinicalTrials.gov registry entry for NCT04388605 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 7,965 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,883-participant average among 99 other Pregnancy Related trials with a reported enrollment target (323% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 0 interventions.

NCT04388605 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04388605 about?

NCT04388605 is a clinical study titled "Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic". Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.

What is the current status of trial NCT04388605?

This trial is currently active not recruiting. The enrollment target is 7,965 participants. The study started on 2020-04-21. Estimated completion is 2026-12.

What conditions does trial NCT04388605 study?

This clinical trial studies the following conditions: Pregnancy Related, Corona Virus Infection, COVID, Early Pregnancy.

Who is sponsoring clinical trial NCT04388605?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04388605 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.